Member Info for hopeabound

It looks promising. If the interims are as they said they are, it surely will pass through 1p comfortably. Distinct possibilities for gamechanging growth with their technologies. I have been runnging some things throught ChatGPT - always cautious about what comes back and this is not advice etc...

KPIs & Catalysts to Watch:

1) Reagent sales run-rate (higher-margin recurring revenue).

2) CTM deployments beyond Doha (multi-year contracts).

3) First commercial PFAS field contracts (mobile MS workflows).

4) SRB kit uptake and repeat orders.

5) Productivity of OEM/distributor channel for Microsaic instruments.

Metier has a competitive edge: Speed & proximity (point-of-need testing), total solution workflow (lab, portable,

online), and strong reagent/consumables pull-through with ISO9001 manufacturing.

The company is still developing, so volatile SP in guaranteed. If you believe in the future prospects of the the company and Ronojn, then clearly, this appears to be a good entry price and I would expect a big bounce. More news to come on their recent announcements. If, voltile is not sor you, then wait until sight of revenues comes into play. If, you are under, hold, and look away for a few days / week. If you are trading, well, good luck. Nothing has changed in terms of the company or it's strategy implementation.

And I can see it undulating around this price until the next bit of news.

Exactly. Nobody would come onto a buleting board, as if we should be a ppreciative of their 'public service' in telling us how bad a share is. They are unpleasant people, acting unpleasantly.

Hurrah! - https://www.londonstockexchange.com/news-article/NFX/us-fda-odd-application-submitted-for-nxp002/17176823 - not expecting great rises or anything but another step along the way.

Marcbought that is.

Sikhthetech in disguise.

Investors will skim, move on, hold, buy more. Hard to evaluate, but momentum and sentiment are strong. More to come as we know with CapMedical and August 22nd explanations. So far, so great. I am holding and will certainly wait until 22nd to decide anything. But, the future for this company looks very good indeed.

Whoosh!

The first paragraph is new. The date on the form is not.

Hoping now that this moves towards profitability. Here is a link to the Turner Pope update. At this price, I see this as a buy, but I am bias, as I hold, and am a little under. But, adding more over last months as it seemed clear the positive direction.

https://www.turnerpope.com/wp-content/uploads/2025/06/Metirplc_30-5-2025_FINAL_BG.pdf

It looks good, even if the initial SP has fallen. I just topped up at 371. Lots of disruption across the pond, but it seems that things are okay there for the time being.

Dr Chris Potts brings over 20 years of senior executive and chair experience of international technology businesses.

Loads of experience. Will be interesting to see what role he will bring. Not clear on that from this but there are indications through his existing roles.

He is presently Chair of proSapient Ltd, a world leading service company based in the UK, with offices in the US, Canada and Portugal, utilising artificial intelligence technology to search for and engage experts who can assist in due diligence processes for leading global management consultancies and private equity firms.

He is also Chair of Zytronic plc; a UK based manufacturing company which supplies sophisticated touch screen technology to a global market. Before that, he was Chair of Guralp Systems limited, a UK based firm which designs, manufactures, and installs seismic sensors for customers globally, for nine years.

Yes. Helps the investment thoughs in rocky price movements. I trust Rathbones better than those anonymous accounts talking down the company.

Well, given I am in this for the long run, I shall be taking advantage of the drop, which is frankly, completely over the top.

Here is a tough quetion to answer. When investing, do I listen to anonymous accounts on LSE trolling the share or do I look at the company RNS and accounts. Good to see the increased holding of Octopus. Oversold. The caveat however, is that there is a corrupt administration about to enter power in the U.S and an unpredictable time ahead. But, despite RFK's child like responses to the science of vaccines, the world still needs them.

Don't respond to him. He offers nothing, and regurgitates the same waffle over and again.

You're probably right.

Yes, there is clearly a seller, but that will dry up. If it goes down below 27, I'll top up.

Exactly that.